Correlation Between Genexine and InBody CoLtd

Can any of the company-specific risk be diversified away by investing in both Genexine and InBody CoLtd at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genexine and InBody CoLtd into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genexine and InBody CoLtd, you can compare the effects of market volatilities on Genexine and InBody CoLtd and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genexine with a short position of InBody CoLtd. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genexine and InBody CoLtd.

Diversification Opportunities for Genexine and InBody CoLtd

0.4

Correlation Coefficient

Genexine  InBody CoLtd

Very weak diversification

The 3 months correlation between Genexine and InBody is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Genexine and InBody CoLtd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InBody CoLtd and Genexine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genexine are associated (or correlated) with InBody CoLtd. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InBody CoLtd has no effect on the direction of Genexine i.e., Genexine and InBody CoLtd go up and down completely randomly.

Pair Corralation between Genexine and InBody CoLtd

Assuming the 90 days trading horizon Genexine is expected to under-perform the InBody CoLtd. In addition to that, Genexine is 1.36 times more volatile than InBody CoLtd. It trades about -0.29 of its total potential returns per unit of risk. InBody CoLtd is currently generating about 0.04 per unit of volatility. If you would invest  2,335,000  in InBody CoLtd on October 24, 2024 and sell it today you would earn a total of  110,000  from holding InBody CoLtd or generate 4.71% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.39%
Values	Daily Returns

Genexine  vs.  InBody CoLtd

Genexine

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Genexine has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

InBody CoLtd

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in InBody CoLtd are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, InBody CoLtd is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Genexine and InBody CoLtd

The main advantage of trading using opposite Genexine and InBody CoLtd positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genexine position performs unexpectedly, InBody CoLtd can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InBody CoLtd will offset losses from the drop in InBody CoLtd's long position.

The idea behind Genexine and InBody CoLtd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.